561K views · 8.2K reactions | Pfizer releases trial results testing the safety of its Covid-19 vaccine for children ages 5-11. These are the first such results released for a US Covid-19 vaccine in this age group. The trial, which included 2,268 participants used a two-dose regimen of the vaccine administered 21 days apart, CNN's Sanjay Gupta reports. | CNN | Facebook

887K views · 3.6K reactions | After ordering 100M doses of the Pfizer vaccine, the Trump administration reportedly turned down the company's offer of an additional 100M-500M doses. More doses of the Pfizer vaccine will not be available until summer 2021 | NowThis Impact | Facebook